{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T10:53:03Z","timestamp":1775731983466,"version":"3.50.1"},"reference-count":9,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T00:00:00Z","timestamp":1582156800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1111\/add.14990","type":"journal-article","created":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T08:40:36Z","timestamp":1582188036000},"page":"933-934","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Commentary on Park <i>et al<\/i>. (2020): Buprenorphine and benzodiazepine co\u2010prescribing\u2010 key considerations and future directions"],"prefix":"10.1111","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8318-3049","authenticated-orcid":false,"given":"Elizabeth M.","family":"Oliva","sequence":"first","affiliation":[{"name":"VA Center for Innovation to Implementation (Ci2i) VA Palo Alto Health Care System  Menlo Park CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,2,20]]},"reference":[{"key":"e_1_2_4_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.14886"},{"key":"e_1_2_4_3_1","doi-asserted-by":"publisher","DOI":"10.7326\/M18-1652"},{"key":"e_1_2_4_4_1","unstructured":"US Food and Drug Administration.FDA Drug Safety Communication: FDA urges caution about withholding opioid addiction medications from patients taking benzodiazepines or CNS depressants: careful medication management can reduce risks.2017. Available at:www.fda.gov\/Drugs\/DrugSafety\/ucm575307.htm(accessed 17 January 2020)."},{"key":"e_1_2_4_5_1","series-title":"Treatment Improvement Protocol (TIP) Series 63, Full Document. HHS Publication no. (SMA) 185063FULLDOC","volume-title":"Medications for Opioid Use Disorder","author":"Substance Abuse and Mental Health Services Administration (SAMHSA)","year":"2018"},{"key":"e_1_2_4_6_1","first-page":"57","article-title":"Practice guidelines: deprescribing benzodiazepine receptor agonists for insomnia in adults","volume":"99","author":"Croke L.","year":"2019","journal-title":"Am Fam Physician"},{"key":"e_1_2_4_7_1","unstructured":"Centers for Medicare and Medicaid Services.Medicare Learning Network (MLN). Reduce Risk of Opioid Overdose Deaths by Avoiding and Reducing Co\u2010Prescribing Benzodiazepines. MLN Matters Number: SE19011.2019. Available at:https:\/\/www.cms.gov\/Outreach\u2010and\u2010Education\/Medicare\u2010Learning\u2010Network\u2010MLN\/MLNMattersArticles\/Downloads\/SE19011.pdf(accessed 16 January 2020)."},{"key":"e_1_2_4_8_1","unstructured":"PopishS. J. WellsD. L.Re\u2010evaluating the Use of Benzodiazepines: A Focus on High\u2010risk Populations. VA Academic Detailing Service.2016. Available at:https:\/\/www.pbm.va.gov\/PBM\/AcademicDetailingService\/Documents\/Academic_Detailing_Educational_Material_Catalog\/22_Benzodiazepine_Provider_AD_Educational_Guide_IB_10_928.pdf(accessed 17 January 2020)."},{"key":"e_1_2_4_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2014.949"},{"key":"e_1_2_4_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjoq-2018-000539"}],"container-title":["Addiction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fadd.14990","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/add.14990","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/add.14990","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/add.14990","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T17:25:32Z","timestamp":1692811532000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/add.14990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,20]]},"references-count":9,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["10.1111\/add.14990"],"URL":"https:\/\/doi.org\/10.1111\/add.14990","archive":["Portico"],"relation":{},"ISSN":["0965-2140","1360-0443"],"issn-type":[{"value":"0965-2140","type":"print"},{"value":"1360-0443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,20]]},"assertion":[{"value":"2020-01-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-24","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}